Vault and vault-like carrier molecules
AssigneeThe Regents of the University of California
InventorsLeonard H. Rome, Valerie A. Kickhoefer, Raval-Fernandes Sujna, Phoebe L. Stewart
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Regents of the University of California
InventorsLeonard H. Rome, Valerie A. Kickhoefer, Raval-Fernandes Sujna, Phoebe L. Stewart
Estimating the term…
A method of using vaults as carrier molecules to deliver one or more than one substance to an organism, or to a specific tissue or to specific cells, or to an environmental medium. A vault-like particle. A method of preventing damage by one or more than one substance to an organism, to a specific tissue, to specific cells, or to an environmental medium, by sequestering the one or more than one substance within a vault-like particle. A method of delivering one or more than one substance or a sensor to an organism, to a specific tissue, to specific cells, or to an environmental medium. According to another embodiment of the present invention, there is provided a method of making vault-like particles, and making vault-like particles comprising one or more than one substance, or one or more than one sensor.
An assembled vault-like particle having a substance to be delivered comprising multiple copies of a modified naturally occurring sequence of MVP, where the naturally occurring sequence of MVP is modified by adding an amino acid sequence to the N-terminal of the naturally occurring sequence of MVP which results in one or more than one substance-binding domain within the assembled vault-like particle, and the substance to be delivered is selected from the group consisting of an enzyme, a pharmaceutical agent, a plasmid, a polynucleotide, a polypeptide, a sensor, and a combination of the preceding.
An assembled vault-like particle comprising multiple copies of a modified naturally occurring sequence of MVP, where the naturally occurring sequence of MVP is modified by adding an amino acid sequence to the N-terminal of the MVP that creates a sensor in the assembled vault-like particle.
An assembled vault-like particle comprising multiple copies of a modified naturally occurring sequence of MVP, where the naturally occurring sequence of MVP is modified by adding an amino acid sequence to the C-terminal of the naturally occurring sequence of MVP which results in one or more than one receptor-binding domain.
An assembled vault-like particle comprising multiple copies of a modified naturally occurring sequence of MVP, where the naturally occurring sequence of MVP is modified by adding both an amino acid sequence to the C-terminal of the naturally occurring sequence of MVP and an amino acid sequence to the N-terminal of the naturally occurring sequence of MVP.
An assembled vault-like particle comprising multiple copies of a naturally occurring sequence of MVP or a modified naturally occurring sequence of MVP, and further comprising a modified naturally occurring sequence of VPARP or a modified portion of the naturally occurring sequence of VPARP comprising at least about 150 consecutive residues from residue 1473 to residue 1724 of VPARP SEQ ID NO:
An assembled vault-like particle comprising multiple copies of a naturally occurring sequence of MVP or a modified naturally occurring sequence of MVP, and further comprising a modified naturally occurring sequence of VPARP or a modified portion of the naturally occurring sequence of VPARP comprising residues from about residue 1562 to 1724 of SEQ ID NO:3 or an intraspecies variation in the sequence thereof in the assembled vault-like particle, wherein the naturally occurring sequence of VPARP or the portion of the naturally occurring sequence of VPARP is modified by adding an amino acid sequence to the C-terminal, adding an amino acid sequence to the N-terminal, or adding an amino acid sequence to the C-terminal and adding an amino acid sequence to the N-terminal of the naturally occurring sequence of VPARP or the portion of the naturally occurring sequence of VPARP.
An assembled vault-like particle comprising multiple copies of a naturally occurring sequence of MVP or a modified naturally occurring sequence of MVP, and further comprising a modified naturally occurring sequence of VPARP or a modified portion of the naturally occurring sequence of VPARP comprising residues from about residue 1473 to 1724 of SEQ ID NO:3 or an intraspecies variation in the sequence thereof in the assembled vault-like particle, wherein the naturally occurring sequence of VPARP or the portion of the naturally occurring sequence of VPARP is modified by adding an amino acid sequence to the C-terminal, adding an amino acid sequence to the N-terminal, or adding an amino acid sequence to the C-terminal and adding an amino acid sequence to the N-terminal of the naturally occurring sequence of VPARP or the portion of the naturally occurring sequence of VPARP.
Dependencies are inferred from the claim text.